14th October 2010
If there are no constraints on antigen choice for a cytosolic or soluble polypeptide or the rationale for choosing an epitope is ambiguous, a pragmatic approach to choosing a peptide sequence for immunization is to synthesize the N-terminal and C-terminal...
Read >
01st October 2010
Pharmaceutical industries are increasingly using biological or biotechnological products for drug development. The biologics or biopharmaceuticals, as they are commonly called, are generally composed of large, complex proteins which may or may not be glyc...
Read >
01st October 2010
Peptide nucleic acid (PNA ) is an artificially synthesized polymer that is capable of binding DNA and RNA in a sequence-specific manner. Since the discovery of its unique binding properties, PNA has been employed in a wide variety of biomedical applicati...
Read >